Corrigendum To: Functional KRAS Mutations and a Potential Role for PI3K/AKT Activation in Wilms Tumors

Molecular Oncology - Netherlands
doi 10.1002/1878-0261.12453
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Wiley

Related search

Recurrent DGCR8, DROSHA, and SIX Homeodomain Mutations in Favorable Histology Wilms Tumors

Cancer Cell
Cancer ResearchOncologyCell Biology
2015English

PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

PDGFRs Are Critical for PI3K/Akt Activation and Negatively Regulated by mTOR

Journal of Clinical Investigation
Medicine
2007English

PIK3CA Hypomethylation Plays a Key Role in Activation of the PI3K/AKT Pathway in Esophageal Cancer in Chinese Patients

Acta Pharmacologica Sinica
MedicinePharmacology
2013English

KRAS Insertion Mutations Are Oncogenic and Exhibit Distinct Functional Properties

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2016English

ARID1A Mutations and PI3K/AKT Pathway Alterations in Endometriosis and Endometriosis-Associated Ovarian Carcinomas

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2013English

Pancreatic Cancer: Circulating Tumor Cells and Primary Tumors Show Heterogeneous KRAS Mutations

Scientific Reports
Multidisciplinary
2017English

Allosteric Activation of PI3Kα By Oncogenic Mutations

Oncotarget
Oncology
2013English

PI3K Signaling Pathway Is Activated by PIK3CA mRNA Overexpression and Copy Gain in Prostate Tumors, but PIK3CA, BRAF, KRAS and AKT1 Mutations Are Infrequent Events

Modern Pathology
Forensic MedicinePathology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy